Applied IV Therapy for the Allergy/Immunology Practice
CREDIT CLAIMING IS NOW OPEN FOR THIS ACTIVITY THROUGH DECEMBER 31, 2017.
Scroll to the bottom of the page to download credit claiming instructions, if needed.
Requests to claim credit on or after January 1, 2018 will be subject to an administrative fee.
Join AAAAI for a new hands-on training program focusing on the use of IV therapies in the allergy/immunology practice. This unique one-day program will include skills training on the fundamentals of intravenous therapy and the short peripheral catheter insertion technique as well as education about the effective incorporation of infusion therapy services into the allergy/immunology practice.
With the growing awareness and number of newly identified immune deficiencies, in addition to the introduction of FDA-approved biologic agents to treat asthma, the modern allergy/immunology practice needs increased knowledge in infusion agents and their mechanisms of action, increased competence in the administration of infusion therapies, and increased confidence in communicating with patients about these treatments. Applied IV Therapy for the Allergy/Immunology Practice will help both physicians and allied health members of your practice address these growing needs.
Special Registration Pricing is Available for the Following Groups:
Credit must be claimed by December 31, 2017. Credit requests on or after January 1, 2018 will be subject to an administrative fee.
Applied IV Therapy for the Allergy/Immunology Practice is funded through an independent educational grant from Teva Pharmaceuticals.
- Allergy/immunology fellows-in-training
- Allied Health providers
Upon completion of this course, participants will be able to:
- Describe the mechanisms of action and appropriate use of allergy/immunology therapeutics administered by IV
- Demonstrate appropriate IV infusion technique, including device selection and catheter insertion, in a simulated setting
- Develop a plan to incorporate infusion therapies into the allergy/immunology practice, including administrative challenges and patient communication needs
Course planners/presenters disclosed the following relevant relationships:
Kristin Epland, NP: Shire (immunoglobulin nurse expert panel)
Stephen J. McGeady, MD FAAAAI: None
Debra A. Sedlak, MSN CPNP: None
Infusion Therapy Institute Instructors:
Rose Koshy, RN BSN CRNI VA-BC
April L. Swenson
ITI instructors disclosed no relevant financial relationship.
CME/MOC Committee reviewer
Samuel Gubernick, DO FAAAAI: None
- 6.50 CECE credit.
- 6.50 CMECME credit.
- 6.50 AttendanceAttendance credit.